-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Insurance Stocks Worth Watching After The Libor Conviction Reversal

Simply Wall St·10/09/2026 18:21:10
Listen to the news

Rate rigging is back in the headlines after the UK Court of Appeal overturned another Libor and Euribor conviction, and that shift in legal tone could ripple through the insurers and legal expense underwriters that handle fallout from financial misconduct. When rules get clearer, pricing of risk can change fast. This article walks through 3 stocks from our UK and European financial lines screener that appear especially exposed to this latest twist in the story.

The three stocks highlighted below are just a starter set from this financial lines theme. The wider screen surfaced four more listed insurers and reinsurers with equally interesting stories that are not covered here.

To size up the full group and quickly analyze where you see the best risk adjusted opportunity, head straight into the UK & European Financial-Lines Insurers and Legal Expense Underwriters screener.

Conduit Holdings (LSE:CRE)

Overview: Conduit Holdings is a Bermuda based reinsurer that backs property, casualty and specialty risks, including financial and directors and officers programs worldwide.

Operations: Conduit Holdings generates $348 million from Property, $262 million from Casualty and $120 million from Specialty reinsurance, largely written across the US and global multi region treaties.

Market Cap: £623 million

Conduit Holdings matters in this financial lines theme because it sits behind many of the complex liability programs that banks and corporates rely on, so clearer rate rigging rules can directly influence how it prices and structures that coverage.

"Shifting toward excess of loss business and investing in technology aims to reduce loss volatility, improve margins, and drive scalable, efficient growth."

What really moves the needle for Conduit Holdings now is how one quiet shift in its liability mix filters through future underwriting margins.

If that underwriting shift is on your radar, the full narrative for Conduit Holdings breaks down how Conduit Holdings' mix, capital and risk appetite could be quietly accelerating change.

LSE:CRE Revenue & Expenses Breakdown as at Oct 2026
LSE:CRE Revenue & Expenses Breakdown as at Oct 2026

SCOR (ENXTPA:SCR)

Overview: SCOR is a Paris based reinsurer that writes life, health and property and casualty cover globally, including specialist financial-lines exposure that fits this screen.

Operations: SCOR generates around €6.7b from Life & Health reinsurance and €4.8b from P&C, with additional unallocated investment income of €914 million.

Market Cap: €5.7b

SCOR matters for this financial-lines theme because its reinsurance sits behind banks and corporates that buy D&O and professional indemnity cover. As a result, any reset in how benchmark manipulation risk is viewed can subtly reshape how that premium pool is shared.

"SCOR is actively positioned to benefit from heightened demand for reinsurance fueled by the increasing frequency of climate-related catastrophes and continued global volatility; this ongoing structural demand supports premium growth and resilient top-line revenue expansion."

The real test will be how one unresolved pressure on its capital and funding costs filters through pricing power and long term underwriting margins.

If that pressure on the capital stack is what you are watching, the full narrative for SCOR shows how SCOR could convert volatility into accelerating reinsurance clout.

ENXTPA:SCR Revenue & Expenses Breakdown as at Oct 2026
ENXTPA:SCR Revenue & Expenses Breakdown as at Oct 2026

Zurich Insurance Group (SWX:ZURN)

Overview: Zurich Insurance Group is a global insurer focused on property, casualty and life cover, with meaningful financial-lines exposure that directly links it to this D&O and professional indemnity screener theme.

Operations: Zurich Insurance Group generates most of its revenue from Property & Casualty in North America and Europe, Middle East & Africa at about $23.7b and $23b respectively, with further contributions from life units and Farmers.

Market Cap: CHF86.6b

Zurich Insurance Group matters here because its financial-lines and specialty book sits at the point where bank liability risk, regulatory clarity and pricing discipline all meet.

"Zurich is strategically pivoting its P&C business toward specialties and mid-market segments while reducing exposure to large corporate and liability lines. The group is seeking to capitalize on increased demand for complex risk management solutions and better pricing discipline, with a focus on revenue and margin performance."

What really shapes the Zurich Insurance Group story now is how one quiet shift in where it takes balance sheet risk filters through future pricing power.

That quiet repositioning of balance sheet risk makes the full narrative for Zurich Insurance Group a useful way to see how Zurich Insurance Group could be quietly accelerating underwriting power and capital flexibility.

SWX:ZURN Revenue & Expenses Breakdown as at Oct 2026
SWX:ZURN Revenue & Expenses Breakdown as at Oct 2026

Seeking Alternatives Before Everyone Else?

Fresh ideas move first. Breakout themes build momentum, early data gets stale, and under the radar for now can get caught quickly. Scan what is flying or dropping and act now.

  • Spot resilient cash generators before they are widely discussed by running through the list of solid balance sheet and fundamentals (9 results) while the pricing still reflects old expectations.
  • Ride long term income trends by reviewing the 1 dividend fortresses that group high yield payers into one place before the next round of payouts sets new expectations.
  • Track where AI infrastructure demand might concentrate by scanning the 92 AI infrastructure stocks while the theme is building momentum but valuations still look driven by fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.